Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × NETWORK × sonidegib × Clear all

Phase

Status

Sponsor Class

OTHER 6 INDUSTRY 5 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Medulloblastoma 1

Interventions

Cisplatin 105 Radiotherapy 100 Paclitaxel 76 Cyclophosphamide 74 Gemcitabine 65 Carboplatin 62 Etoposide 46 Docetaxel 46 Fluorouracil 45 Filgrastim 45 Doxorubicin 45 Vincristine 41 Leucovorin 35 Cytarabine 34 Methotrexate 33 Prednisone 32 Dexamethasone 32 Capecitabine 32 Irinotecan 31 Oxaliplatin 27 Rituximab 24 Cetuximab 23 durvalumab 22 Temozolomide 21 Surgical Procedures, Operative 21 Radiotherapy, Intensity-Modulated 21 Magnetic Resonance Spectroscopy 21 Bevacizumab 21 Bortezomib 20 Peripheral Blood Stem Cell Transplantation 19

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04402073 2025-10-23

PersoMed-I

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Terminated

Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡